A Phase 3, Multi-center, Randomized Study Evaluating Efficacy of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-Invasive Urothelial Carcinoma (MIBC) of the Bladder who are not Receiving Radical Cyst

Project: Research project

Project Details

StatusActive
Effective start/end date6/11/21 → 6/10/26

Funding

  • Janssen Pharmaceutical Research and Development: $16,625.00